Casey Eye Institute
Portland, Oregon 97239
4 studies enrolling now · 40 studies all time
What they study most
AMD, Age Related Macular Degeneration, Amblyopia, Anterior Uveitis, Cataract, Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy, Diabetes, Diabetic Macular Edema, Diabetic Retinopathy, Dry Age-related Macular Degeneration, Eales' Disease, Geographic Atrophy
Studies at this site
- A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control — Recruiting now
- Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age — Recruiting now
- A Randomized Trial to Evaluate Sequential vs Simultaneous Patching — Recruiting now
- Full-Time Occlusion Therapy for Intermittent Exotropia in Children — Completed
- Low-Dose Atropine for Treatment of Myopia — Completed
- Trial of Overminus Spectacle Therapy for Intermittent Exotropia — Completed
- A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP — Stopped early
- Promising ROd-cone DYstrophy Gene therapY — Running, not enrolling
- A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) — Completed
- Bevacizumab Treatment For Type 1 ROP — Running, not enrolling
- EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 — Stopped early
- A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) — Completed
- A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US — Completed
- A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN) — Enrolling by invitation
- A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE) — Running, not enrolling
- Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations — Running, not enrolling
- A Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) — Stopped early
- A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Stopped early
- Anti-VEGF Treatment for Prevention of PDR/DME — Completed
- Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy — Completed
- Anti-VEGF vs. Prompt Vitrectomy for VH From PDR — Completed
- Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema — Completed
- Treatment for CI-DME in Eyes With Very Good VA Study — Completed
- Evaluation of Vitrectomy for Diabetic Macular Edema — Completed
- Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema — Completed
- Lucentis (Ranibizumab) for Eales' Disease — Completed
- Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration — Completed
- Phase II Combination Steroid and Anti-VEGF for Persistent DME — Completed
- Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial — Completed
- Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema — Completed
- The Course of Response to Focal Photocoagulation for DME — Completed
- Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy — Completed
- Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control — Completed
- A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) — Completed
- Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia — Stopped early
- Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis — Completed
- Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery — Completed
- Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD) — Completed
- Complications of Age-Related Macular Degeneration Prevention Trial — Completed
- Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) — Completed